Perbandingan nilai Q GERD pasien bpjs rawat jalan yang mendapat terapi antasida DAN omeprazol dengan antasida DAN lanzoprazol DI klinik pratama X sidoarjo
Abstract
Introduction: Gastroesophageal Reflux Disease (GERD) is a digestive tract disorder characterized by repeated reflux of stomach contents into the esophagus, causing various symptoms such as heartburn, regurgitation, heartburn, and sleep disorders. The prevalence of GERD throughout the world ranges from 15%-25%, with an increasing trend in several countries including Indonesia. Objective: This study aims to compare the Q value of GERD for outpatient BPJS patients who received combination therapy with antacid + PPI drugs [Omeprazole or lanzoprazole]. Method: This research uses a descriptive research type using a cross sectional research design, evaluated with the GERD-Q Questionnaire. Results: The results in this research are that the drugs used for GERD therapy are PPI and antacids based on research results showing that this therapy can effective in reducing the symptoms of gerd experienced by patients, the combination of antacid + lansoprazole/omeprazole + antacid is very effective in reducing the Q value of gerd from statistical data showing that the reduction between the 2 combinations is not significantly different P<0. Conclusion: The average decrease in the Q value of GERD for outpatient BPJS patients who received antacid + omeprazole, and antacid +lansoprazole therapy at the Pratama X Sidoarjo clinic was 7.25, and 9.875.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.